InsurTech Investors & VC Firms in Toronto
12 firms in this list, with a median first check of $2M. 3 of them lead rounds. Generated from verified public data and updated continuously.
OMERS Ventures
TorontoPre-Seed–Series B$5M – $25M
30 people
Clairvest Group Inc
TorontoGrowth–Late Stage$25M – $100M
58 people
Impression Ventures
TorontoSeed–Series A$2M
11 people
Relay Ventures
TorontoPre-Seed–Series A$500K – $10M
9 people
GroundBreak Ventures
TorontoPre-Seed–Series A
14 people
Highline Beta
TorontoPre-Seed–Growth
18 people
Intact Ventures
TorontoSeed–Growth$1.5M – $7.3M
7 people
Investment Management Corporation of Ontario
TorontoGrowth–Late Stage
Fairfax Financial corporate venture activity
TorontoSeed–Growth
Thomson Reuters Ventures
New YorkSeed–Series A
10 people
Portage Ventures
MontrealPre-Seed–Late Stage
5 people
Portag3 Ventures
MontrealSeed–Late Stage
1 person
Frequently asked questions
- Who are the top insurtech investors & vc firms in toronto?
- Top insurtech investors & vc firms in toronto include OMERS Ventures, Clairvest Group Inc, Impression Ventures, Relay Ventures, GroundBreak Ventures, Highline Beta, Intact Ventures, Investment Management Corporation of Ontario — 12 firms in total meet the criteria.
- What is the typical first check among insurtech investors & vc firms in toronto?
- The median first check among the 12 insurtech investors & vc firms in toronto tracked here is $2M.
- How many insurtech investors & vc firms in toronto lead rounds?
- 3 of the 12 insurtech investors & vc firms in toronto tracked here lead investment rounds.
Related lists
Investors & VC Firms in North America (14074)Investors & VC Firms in United States (13215)Investors & VC Firms in Europe (5565)Crypto & Web3 Investors & VC Firms (4819)Investors & VC Firms in Global (4147)SaaS Investors & VC Firms (3842)AI & Machine Learning Investors & VC Firms (3754)Fintech Investors & VC Firms (3710)Investors & VC Firms in Asia-Pacific (3567)Healthtech Investors & VC Firms (3393)
Data sourced from public filings and firms' own websites — see our methodology.





























